An immune and epithelial–mesenchymal transition-related risk model and immunotherapy strategy for grade II and III gliomas

Grade II and III gliomas are heterogeneous and aggressive diseases. More efficient prognosis models and treatment methods are needed. This study aims to construct a new risk model and propose a new strategy for grade II and III gliomas. The data were downloaded from The Cancer Genome Atlas (TCGA), t...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Wei, Quan, Qi, Jiang, Jiaxin, Peng, Roujun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9909968/
https://www.ncbi.nlm.nih.gov/pubmed/36778912
http://dx.doi.org/10.3389/fgene.2022.1070630

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9909968/
https://www.ncbi.nlm.nih.gov/pubmed/36778912
http://dx.doi.org/10.3389/fgene.2022.1070630

Ejemplares similares